A recent study published in the journal JAMA evaluated the efficacy and side effects of donanemab. They aimed to use this antibody to clear brain amyloid plaque in randomized participants with early symptomatic Alzheimer disease (AD) with low/medium or high tau pathology.
Read more “Donanemab: A trailblazer for Alzheimer’s disease treatment?”
Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress
It’s time to stop prevaricating and explore the use of psilocybin—the active ingredient in ‘magic mushrooms’—and other psychedelics to ease the often overwhelming distress faced by women with late stage gynecological cancers, urge doctors in a commentary published online in the International Journal of Gynecological Cancer.
Read more “Doctors urge more research on the use of psilocybin and other psychedelics”
